Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway
Oncology Reports · 14.05.2026 · 56 (1) · 1-12
DOI: 10.3892/or.2026.9136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 14.05.2026. Verfasst von Huili Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pet Science and Technology, Henan Vocational College of Agriculture, Zhengzhou, Henan 451450, P.R. China. Hauptthemen laut MEDLINE: Metformin, Ivermectin, Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pet Science and Technology, Henan Vocational College of Agriculture, Zhengzhou, Henan 451450, P.R. China.
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, P.R. China.
Zitieren
APA
Feng, H., He, L., Umar, T., Wang, H., Gao, Y., Chen, G., Sun, P., Yin, L., Zhao, W., Lu, H., Deng, G., & Qiu, C. (2026). Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway. Oncology Reports, 56(1), 1-12. https://doi.org/10.3892/or.2026.9136
Vancouver
Feng H, He L, Umar T, Wang H, Gao Y, Chen G, et al. Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway. Oncology Reports. 2026;56(1):1-12. doi:10.3892/or.2026.9136
BibTeX
@article{Feng2026,
author = {Feng, Huili and He, Lixin and Umar, Talha and Wang, Haipeng and Gao, Yanling and Chen, Gongyi and Sun, Panfeng and Yin, Ling and Zhao, Wenbin and Lu, Huifang and Deng, Ganzhen and Qiu, Changwei},
title = {Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway},
journal = {Oncology Reports},
year = {2026},
volume = {56},
number = {1},
pages = {1--12},
doi = {10.3892/or.2026.9136}
}
EUVIMED